ArticleCancer management and research2021

Improvement of outcomes of an escalated high-dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.